Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD

Stefan Andreas1 Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany;2 LungClinic Immenhausen, Immenhausen, Germany, Member of the German Center for Lung Research (DZL)Correspondence[email protected]

https://orcid.org/0000-0003-3918-6909

Lorcan McGarvey3 Queen’s University Belfast, Belfast, UK

Ulrich Bothner4 Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

Matthias Trampisch4 Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

Alberto de la Hoz4 Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

Matjaz Fležar5 Klinika Golnik, Golnik, Slovenia

Roland Buhl6 Pulmonary Department, Johannes Gutenberg University Mainz, Mainz, Germany

Peter Alter7 Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University of Marburg (UMR), Marburg, Germany, Member of the German Center for Lung Research (DZL)

https://orcid.org/0000-0002-2115-1743

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date